How Patients Lose Their Own Voices: Disparities in Patient-Reported Outcome Capture in Clinical Trials
It remains important to interrogate how structural discrimination influences the collection of patient-reported outcomes.
Bone Cancer
BONE CANCER ADVISOR
FEATURED CONTENT
-
-
Children With Cancer Not Experiencing as Severe COVID-19 as Initially Feared
Studies suggest that the majority of pediatric patients with cancer and COVID-19 experience mild disease — rather than severe disease — as a result of infection with the novel virus. -
Upfront Radiation May Be a Cost-Effective Strategy in Oligorecurrent Hormone-Sensitive Prostate Cancer
Upfront metastasis-directed therapy may be a viable treatment approach in patients with oligorecurrent disease, particularly those who wish to defer systemic therapy. -
New Class of Drug Appears to Extend Survival in Patients With Triple-Refractory Multiple Myeloma
Oncopeptides will seek accelerated approval from the FDA after melflufen demonstrates a manageable safety profile. -
Study Points to a Rise in Renal Carcinomas in Children
The increase is thought to be related to environmental factors.
BONE CANCER NEWS
Crysvita Approved for Treatment of Tumor-Induced Osteomalacia
Strontium89 Now Available for Relief of Metastatic Bone Pain
FDA Grants Orphan Drug Designation to BN-Brachyury for Chordoma
CTA Treatment Regimen Chart for Bone Cancer Updated
Baseline EFS Outcomes Identified for Recurrent/Refractory Pediatric Osteosarcoma
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Bone Cancer
